These findings help your provider personalize your injection dose and frequency for maximum effectiveness
All participants had overweight or obesity (BMI 27 kg/m) and pre-existing cardiovascular disease (CVD) but notably no diabetes
Interventions that support mitochondrial efficiency, stabilize nutrient sensing, and limit the accumulation of senescent cells may contribute to preserving physiological resilience, even if they do not directly alter the primary drivers of aging
Glutamine provides mitochondrial anaplerosis because of its role as a nitrogen and carbon donor to the cells [32]
Diet in the treatment of epilepsy: what we know so far
Similarly, the American Association of Clinical Endocrinology's (AACE) 2023 Consensus Statement on type 2 diabetes management emphasizes that GLP-1RAs are preferred medications in patients who are classified as overweight or obese, have a risk of hypoglycemia, and/or have severe hyperglycemia [4]